Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
14.12
-0.70 (-4.72%)
Oct 22, 2026, 5:30 PM CEST

SWX:SANN Revenue

Santhera Pharmaceuticals Holding AG had revenue of 48.33M CHF in the half year ending June 30, 2026, with 242.43% growth. This brings the company's total for the last twelve months to 101.50M, up 107.08% year-over-year. In the year 2025, Santhera Pharmaceuticals Holding AG had annual revenue of 77.19M with 97.32% growth. That makes Santhera Pharmaceuticals Holding AG the 21,087th largest company in the world by revenue and 163rd in Switzerland.

Revenue (ttm)
101.50M
Revenue Growth
+107.08%
P/S Ratio
2.23
Revenue / Employee
1.08M
Employees
94
Market Cap
216.06M

Revenue Chart

Revenue by Geography

  • North America 46.29M 60.0%
  • Europe 24.38M 31.6%
  • Asia 6.52M 8.4%
Fiscal year ended Dec 31, 2025 See the full SWX:SANN breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202577.19M38.07M97.32%
Dec 31, 202439.12M-64.30M-62.17%
Dec 31, 2023103.41M95.94M1,283.84%
Dec 31, 20227.47M9.07M-
Dec 31, 2021-1.60M-16.60M-
Dec 31, 202015.01M-60.37M-80.09%
Dec 31, 201975.38M43.72M138.10%
Dec 31, 201831.66M8.71M37.98%
Dec 31, 201722.94M3.91M20.54%
Dec 31, 201619.03M14.71M340.48%
Dec 31, 20154.32M1.73M66.77%
Dec 31, 20142.59M1.27M96.44%
Dec 31, 20131.32M-2.22M-62.72%
Dec 31, 20123.54M273.00K8.36%
Dec 31, 20113.27M-17.34M-84.16%
Dec 31, 201020.61M-1.73M-7.74%
Dec 31, 200922.34M22.29M46,439.58%
Dec 31, 200848.00K-9.18M-99.48%
Dec 31, 20079.23M8.45M1,081.31%
Dec 31, 2006781.00K--
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.